Similarly, TB-500 has undergone extensive safety evaluation including human research trials showing safety at intravenous doses up to 1,260 mg equivalent, with no dose-limiting toxicities or serious adverse events attributable to the peptide in carefully controlled studies
But what happens when you run low
For most patients, the demonstrated benefits substantially outweigh known risks
doi: 10.1016/j.amjcard.2004.06.047
I. Schelleret al., Thymosin 4 is essential for thrombus formation by controlling the G-actin/F-actin equilibrium in platelets, Ferrata Storti Foundation (Haematologica), Aug. 2021. doi: 10.3324/haematol.2021.278537
Furthermore, the blend is commonly researched for its potential to support lean body mass maintenance and positive nitrogen balance